Moderna Expects To Report Covid Vaccine Trial Data In Children 2-5 Yrs In March

Moderna Inc. said it expects to report Covid-19 vaccine trial data in children 2-5 years of age in March. The vaccine maker plans to proceed with regulatory filings for children in this age group if the data is supportive and subject to regulatory consultation. In a statement, the company noted that the U.S. Food and Drug Administration or FDA requested additional participants at a given dose...

from RTT - Top Story https://ift.tt/3zWaR4P
via IFTTT